{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:33:37Z","timestamp":1783038817585,"version":"3.54.6"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32GM007250-45"],"award-info":[{"award-number":["5T32GM007250-45"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtha.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:26:06Z","timestamp":1772641566000},"page":"2103-2111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["What constitutes high risk for venous thromboembolism? Determining an appropriate threshold to initiate prophylaxis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-5822","authenticated-orcid":false,"given":"Benjamin G.","family":"Mittman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.02.004_bib1","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism: a public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ajh.20983","article-title":"Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism","volume":"82","author":"Anderson","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.02.004_bib3","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/j.1538-7836.2006.02196.x","article-title":"Estimation of a potentially preventable fraction of venous thromboembolism: a community-based prospective study","volume":"4","author":"Noboa","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.02.004_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.02.004_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib8","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/CCM.0b013e31828cf104","article-title":"Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-2897-4-1","article-title":"Complications related to deep venous thrombosis prophylaxis in trauma: a systematic review of the literature","volume":"4","author":"Datta","year":"2010","journal-title":"J Trauma Manag Outcomes"},{"key":"10.1016\/j.jtha.2026.02.004_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejim.2023.11.017","article-title":"Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis","volume":"121","author":"Le Gal","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib11","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.02.004_bib12","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.02.004_bib13","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1161\/CIR.0000000000000818","volume":"142","author":"Cushman","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.02.004_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-155-9-201111010-00011","article-title":"Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians","volume":"155","author":"Qaseem","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.amjmed.2011.06.004","article-title":"Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients","volume":"124","author":"Woller","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib16","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11239-010-0455-7","article-title":"Variation in physician deep vein thrombosis prophylaxis attitudes and practices at an academic tertiary care center","volume":"30","author":"Galbraith","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2026.02.004_bib18","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1182\/blood-2019-131827","article-title":"Potential overuse of primary thromboprophylaxis in medical inpatients at low risk of venous thromboembolism","volume":"134","author":"Djulbegovic","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.004_bib19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamainternmed.2018.2022","article-title":"Use of venous thromboembolism prophylaxis in hospitalized patients","volume":"178","author":"Grant","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.12788\/jhm.2916","article-title":"Poor adherence to risk stratification guidelines results in overuse of venous thromboembolism prophylaxis in hospitalized older adults","volume":"13","author":"Pavon","year":"2018","journal-title":"J Hosp Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jtha.2026.02.004_bib22","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/healthcare11162244","article-title":"Optimizing clinical decision making with decision curve analysis: insights for clinical investigators","volume":"11","author":"Piovani","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.jtha.2026.02.004_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2020-100247","article-title":"Enhancing trust in clinical decision support systems: a framework for developers","volume":"28","author":"Jones","year":"2021","journal-title":"BMJ Health Care Inform"},{"key":"10.1016\/j.jtha.2026.02.004_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9980","article-title":"Risk assessment models for venous thromboembolism in medical inpatients","volume":"7","author":"H\u00e4fliger","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtha.2026.02.004_bib25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/jth.14796","article-title":"Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: a cohort study","volume":"18","author":"Moumneh","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.02.004_bib27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1055\/a-1698-6506","article-title":"Derivation and validation of a risk factor model to identify medical inpatients at risk for venous thromboembolism","volume":"122","author":"Rothberg","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib28","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.jtha.2024.06.025","article-title":"Development and internal validation of the Cleveland Clinic Bleeding Model to predict major bleeding risk at admission in medical inpatients","volume":"22","author":"Mittman","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib49","series-title":"missForest: nonparametric missing value imputation using Random Forest. R package version 1.6.1","author":"Stekhoven","year":"2025"},{"key":"10.1016\/j.jtha.2026.02.004_bib29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/jth.13687","article-title":"A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients","volume":"15","author":"Le","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom J"},{"key":"10.1016\/j.jtha.2026.02.004_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000150640.98772.af","article-title":"Preventing venous thromboembolism in medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.02.004_bib32","article-title":"Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)","volume":"2014","author":"Alikhan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2026.02.004_bib33","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1538-7836.2007.02650.x","article-title":"Thromboprophylaxis rates in US medical centers: success or failure?","volume":"5","author":"Amin","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"371","author":"Cohen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.02.004_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1378\/chest.106.1.13","article-title":"Utilization of venous thromboembolism prophylaxis in the medical intensive care unit","volume":"106","author":"Keane","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.02.004_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.1995.03530040063042","article-title":"Prevalence of deep venous thrombosis among patients in medical intensive care","volume":"274","author":"Hirsch","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.02.004_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102184","article-title":"Overuse and underuse of thromboprophylaxis in medical inpatients","volume":"7","author":"Kocher","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.004_bib38","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s11606-020-05993-x","article-title":"Overuse of primary thromboprophylaxis in medical inpatients at low risk of venous thromboembolism","volume":"36","author":"Djulbegovic","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib39","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1182\/blood.V126.23.5563.5563","article-title":"Overuse of DVT prophylaxis in medical inpatients","volume":"126","author":"Deng","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.004_bib40","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/bloodadvances.2024013166","article-title":"Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis","volume":"8","author":"Djulbegovic","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.02.004_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2016-12-758995","article-title":"Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US","volume":"130","author":"Heit","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.004_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-019-1425-3","article-title":"Topic Group \u2018Evaluating diagnostic tests and prediction models\u2019 of the STRATOS initiative. Three myths about risk thresholds for prediction models","volume":"17","author":"Wynants","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11606-010-1296-y","article-title":"Venous thromboembolism prophylaxis among medical patients at US hospitals","volume":"25","author":"Rothberg","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib44","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jamainternmed.2014.3384","article-title":"Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study","volume":"174","author":"Flanders","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1370\/afm.2908","article-title":"Barriers and facilitators to the use of clinical decision support systems in primary care: a mixed-methods systematic review","volume":"21","author":"Meunier","year":"2023","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib46","doi-asserted-by":"crossref","first-page":"1001.e9","DOI":"10.1016\/j.amjmed.2016.03.031","article-title":"Validation of risk assessment models of venous thromboembolism in hospitalized medical patients","volume":"129","author":"Greene","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3762651","article-title":"Defining an optimal cut-point value in ROC analysis: an alternative approach","volume":"2017","author":"Unal","year":"2017","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.jtha.2026.02.004_bib48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann Intern Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:06:35Z","timestamp":1780574795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1538783626001200"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.004","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What constitutes high risk for venous thromboembolism? Determining an appropriate threshold to initiate prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}